Ann Pediatr Endocrinol Metab.  2023 Dec;28(4):233-234. 10.6065/apem.2322107edi009.

Commentary on "Glycemic control and complications of type 2 diabetes mellitus in children and adolescents during the COVID-19 outbreak"

• Cheon CK

• KMID: 2549313
• DOI: http://doi.org/10.6065/apem.2322107edi009

Reference

References

1. Prosperi S, Chiarelli F. COVID-19 and diabetes in children. Ann Pediatr Endocrinol Metab. 2022; 27:157–68.

2. Lange SJ, Kompaniyets L, Freedman DS, Kraus EM, Porter R, Goodman AB. Longitudinal trends in body mass index before and during the COVID-19 pandemic among persons aged 2-19 years - United States, 2018-2020. MMWR Morb Mortal Wkly Rep. 2021; 70:1278–83.

3. Kang S, Seo MY, Kim SH, Park MJ. Changes in lifestyle and obesity during the COVID-19 pandemic in Korean adolescents: based on the Korea Youth Risk Behavior Survey 2019 and 2020. Ann Pediatr Endocrinol Metab. 2022; 27:281–8.

4. Zahedi M, Kordrostami S, Kalantarhormozi M, Bagheri M. A review of Hyperglycemia in COVID-19. Cureus. 2023; 15:e37487.

5. Pal R, Banerjee M, Yadav U, Bhattacharjee S. Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature. Diabetes Metab Syndr. 2020; 14:1563–9.

6. Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020; 14:211–2.

7. Rajagopalan S. Serious infections in elderly patients with diabetes mellitus. Clin Infect Dis. 2005; 40:990–6.

8. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020; 55:2000547.

9. Khare J, Jindal S. Observational study on effect of lock down due to COVID 19 on glycemic control in patients with diabetes: experience from Central India. Diabetes Metab Syndr. 2020; 14:1571–4.

10. Tanji Y, Sawada S, Watanabe T, Mita T, Kobayashi Y, Murakami T, et al. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: a hospital-based survey from a country without lockdown. Diabetes Res Clin Pract. 2021; 176:108840.

11. Park SD, Kim SW, Moon JS, Lee YY, Cho NH, Lee JH, et al. Impact of social distancing due to coronavirus disease 2019 on the changes in glycosylated hemoglobin level in people with type 2 diabetes mellitus. Diabetes Metab J. 2021; 45:109–14.

12. Ghesquière L, Garabedian C, Drumez E, Lemaître M, Cazaubiel M, Bengler C, et al. Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: a retrospective study. Diabetes Metab. 2021; 47:101201.

13. Eberle C, Stichling S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 2021; 13:95.

14. Psoma O, Papachristoforou E, Kountouri A, Balampanis K, Stergiou A, Lambadiari V, et al. Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes. J Diabetes Complications. 2020; 34:107756.

15. Önmez A, Gamsızkan Z, Özdemir Ş, Kesikbaş E, Gökosmanoğlu F, Torun S, et al. The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey. Diabetes Metab Syndr. 2020; 14:1963–6.

16. Magge SN, Wolf RM, Pyle L, Brown EA, Benavides VC, Bianco ME, et al. COVID-19 and type 2 diabetes consortium. The coronavirus disease 2019 pandemic is associated with a substantial rise in frequency and severity of presentation of youth-onset type 2 diabetes. J Pediatr. 2022; 251:51–59.e2.

17. Oh KE, Kim YJ, Oh YR, Kang E, Nam HK, Rhie YJ, et al. Glycemic control and complications of type 2 diabetes mellitus in children and adolescents during the COVID-19 outbreak. Ann Pediatr Endocrinol Metab. 2023; 28:275–82.